Voyager Therapeutics (VYGR) Other Operating Expenses (2016)
Voyager Therapeutics' (VYGR) quarterly Other Operating Expenses came in at $1000.0 in Q4 2016.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Other Operating Expenses (2016) Analysis & Trends
Voyager Therapeutics has disclosed Other Operating Expenses across 1 years of filings, most recently posting $1000.0 for Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.39 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.70 Bn | 3.41 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.57 Bn | 2.60 Bn | 251.50 Mn |
| 5 | uniQure | 3.02 Bn | 3.02 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.41 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 190.42 Mn | 74.09 Mn | - |